
    
      In dose escalation stage (Phase 1 part), low/intermediate/high dose of GX-I7 will be
      administered in combination with adjuvant temozolomide to find recommended phase 2 dose.

      Phase 2 part will be randomized, placebo controlled study and GX-I7 or Placebo will be
      administered in combination with adjuvant temozolomide treatment.
    
  